This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever

NCT07445282 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER_GOV

Sponsor class

Conditions

Extensively Drug-Resistant Typhoid Fever
Typhoid Fever
Salmonella Typhi Infection

Interventions

DRUG: Meropenem
DRUG: Azithromycin + Metronidazole

Sponsor

Sheikh Zayed Medical College